ArticleJournal of clinical medicine research2026
Perioperative and Long-Term Outcomes of T-Shaped Esophagojejunostomy After Laparoscopic Total Gastrectomy for Gastric Cancer.
Article in Journal of clinical medicine research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intracorporeal esophagojejunostomy remains a technically challenging step in totally laparoscopic total gastrectomy (TLTG), and long-term outcome data for modified linear-stapled techniques are limited. Methods: We conducted an observational study including 167 consecutive patients who underwent TLTG with D2 lymphadenectomy and intracorporeal T-shaped functional end-to-end esophagojejunostomy between July 2017 and July 2025. Perioperative outcomes, postoperative complications, and long-term oncologic outcomes were analyzed. Results: All procedures were completed laparoscopically without conversion to open surgery. No anastomotic leakage occurred. Overall postoperative morbidity was 2.4%, and no postoperative mortality was observed. The mean follow-up duration was 44.1 ± 20.0 months, with complete survival follow-up. The 5-year overall survival rate was 41.8%. Conclusions: T-shaped functional end-to-end esophagojejunostomy after TLTG is safe and reproducible, with low anastomotic-related morbidity and acceptable long-term oncologic outcomes. These findings provide real-world evidence supporting standardized intracorporeal reconstruction following total gastrectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.